Skip to main content
All lobbying clients

ASSOCIATION FOR ACCESSIBLE MEDICINES

Lobbying client · District of Columbia · filed 2025 to 2026

$4,800,000 Reported spend
6 Filings counted
1 Firms hired
30 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (121533), not by name.

 Firms hired 1
 Bills named in these filings 30
  • S 1041
    Affordable Prescriptions for Patients Act
    6 filings
  • S 1096
    Preserve Access to Affordable Generics and Biosimilars Act
    6 filings
  • S 43
    Skinny Labels, Big Savings Act
    6 filings
  • HR 1051
    To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug applic…
    5 filings
  • HR 1843
    To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
    5 filings
  • HR 3152
    Patent Eligibility Restoration Act of 2025
    5 filings
  • HR 3160
    PREVAIL Act
    5 filings
  • HR 3269
    ETHIC Act
    5 filings
  • S 1302
    Increasing Transparency in Generic Drug Applications Act
    5 filings
  • S 1414
    Expedited Access to Biosimilars Act
    5 filings
  • S 1546
    Patent Eligibility Restoration Act of 2025
    5 filings
  • S 1553
    PREVAIL Act
    5 filings
  • S 1954
    Biosimilar Red Tape Elimination Act
    5 filings
  • HR 1396
    PILLS Act
    4 filings
  • HR 4132
    Prescription Information Modernization Act of 2025
    4 filings
  • HR 5526
    Biosimilar Red Tape Elimination Act
    4 filings
  • S 1040
    Drug Competition Enhancement Act
    4 filings
  • S 2027
    Prescription Information Modernization Act of 2025
    4 filings
  • S 2276
    ETHIC Act
    4 filings
  • HR 3955
    RAPID Reserve Act
    3 filings
  • HR 5811
    Restoring America’s Leadership in Innovation Act of 2025
    3 filings
  • HR 6485
    Skinny Labels, Big Savings Act
    3 filings
  • S 1097
    Interagency Patent Coordination and Improvement Act of 2025
    3 filings
  • S 1784
    MAPS Act
    3 filings
  • S 1891
    PILLS Act
    3 filings
  • S 2062
    RAPID Reserve Act
    3 filings
  • S 3469
    BIOSECURE Act of 2025
    3 filings
  • HR 4191
    MAPS Act
    2 filings
  • HR 4570
    Interagency Patent Coordination and Improvement Act of 2025
    2 filings
  • HR 7148
    Consolidated Appropriations Act, 2026
    2 filings
 Reported by year 2 years
  • 2026 $1,710,000 2 filings
  • 2025 $3,090,000 4 filings
 Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 19
  • Centers For Medicare and Medicaid Services (CMS) 6
  • Health & Human Services, Dept of (HHS) 6
  • HOUSE OF REPRESENTATIVES 6
  • SENATE 6
  • U.S. Trade Representative (USTR) 6
  • White House Office 6
  • Commerce, Dept of (DOC) 5
  • Food & Drug Administration (FDA) 5
  • Natl Economic Council (NEC) 5
  • U.S. Customs & Border Protection 5
  • Office of Management & Budget (OMB) 4
  • Congressional Budget Office (CBO) 3
  • Federal Trade Commission (FTC) 3
  • Drug Enforcement Administration (DEA) 1
  • Justice, Dept of (DOJ) 1
  • Office of Science & Technology Policy (OSTP) 1
  • Office of the Vice President of the United States 1
  • Patent & Trademark Office (PTO) 1
  • State, Dept of (DOS) 1

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem